APArmando Partida-Gaytan

Armando Partida-Gaytan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Armando Partida-Gaytan has a total of 153 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantity and Quality of Dairy Product Intake and Their Relationship with Body Composition in Children and Adolescents from Mexico City

    by Armando Partida-Gaytan, Diana Montiel-Ojeda, Patricia Clark, Desiree Lopez-Gonzalez

    Background: The association between milk-derived or dairy product intake (DPI) and the body composition (BC) of children and adolescents continues to be controversial. Objective: This study sought to evaluate the association between the quantity and quality of DPI and the BC of Mexican children and adolescents. Methods: A secondary data analysis of a cross-sectional population-based sample of 2104 children and adolescents (aged 4–18 years) recruited from schools in Mexico City was performed. To assess the association between the quantity and quality of DPI, evaluated by questionnaire, and BC, dual X-ray densitometry (DXA) and surrogate parameters of the fat mass index (FMI) and lean mass index (LMI) were used. The adequacy of the quantity and quality of DPI was classified according to age-specific recommendations and the sugar, sodium and fat contents of the products consumed. Relationships were assessed by means of lineal regressions adjusted for age, sex, physical activity, sleep time and screen hours. Results: We included a total of 1840 participants aged 4.5–18 years, 52% of whom were female. Average daily DPI was 4.0 ± 2.4 servings/day, with a predominance of milk without sugar (42.7% of DPI). The quantity and quality of DPI significantly reduced the FMI (beta = −0.1 kg/m2, 95% CI −0.17 to −0.06, p < 0.001 and beta = −0.17 kg/m2, 95% CI −0.26 to −0.07, p < 0.001). No significant relationships were seen with the LMI. Conclusions: Higher quantities of good-quality DPI are associated with lower adiposity in Mexican children and adolescents.

  • Open Access

    Reference values for body composition in healthy urban Mexican children and adolescents

    by Lopez-Gonzalez Desiree, Jonathan C Wells, Partida-Gaytan Armando, Cortina-Borja Mario, Clark Patricia

    Introduction: Given the increasing incidence of chronic degenerative diseases related to changes in tissues, the availability of diagnostic tools with greater accuracy in the estimation of body composition (BC) has become necessary. Interpreting the BC values of individuals requires reference data obtained from a healthy population with the same ethnicity, to identify individuals at risk for the development of negative health outcomes. Objective: Generate reference values (RV) of body composition (BC) for Mexican children and adolescents. Methods: This was an urban-population-based cross-sectional study of healthy Mexican children and adolescents. BC estimations by anthropometry, multifrequency bioimpedance analysis (MF-BIA) and dual-energy X-ray absorptiometry (DXA) where used to create sex- and age-specific RV by means of generalized additive models for location, scale and shape (GAMLSS). Results: We assessed 2104 subjects, and after confirming a clinically and metabolically healthy status, we measured 1659 subjects aged 5–20 years, [806 females (49%) and 853 males (51%)] by anthropometry, MF-BIA and DXA to create sex- and age- smoothed reference centiles, lambda (L), mu (M), and sigma (S) values. We also built sex- and age-smoothed graphic curves for each variable of interest. Conclusions: We present valid RV and curves for BC variables estimated by anthropometry, MF-BIA and DXA from clinically and metabolically healthy urban Mexican children and adolescents. These RV are different from those reported for other populations, and therefore, should be used for clinical and research purposes involving urban Mexican children and adolescents.


  • Open Access

    HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation

    by Yanxin Fan, Marta Murgia, Monika I. Linder, Yoko Mizoguchi, Cong Wang, Marcin Łyszkiewicz, Natalia Ziȩtara, Yanshan Liu, Stephanie Frenz, Gabriela Sciuccati, et al.

    The relevance of molecular mechanisms governing mitochondrial proteostasis to the differentiation and function of hematopoietic and immune cells is largely elusive. Through dissection of the network of proteins related to HCLS1-associated protein X-1, we defined a potentially novel functional CLPB/HAX1/(PRKD2)/HSP27 axis with critical importance for the differentiation of neutrophil granulocytes and, thus, elucidated molecular and metabolic mechanisms underlying congenital neutropenia in patients with HAX1 deficiency as well as bi- and monoallelic mutations in CLPB. As shown by stable isotope labeling by amino acids in cell culture (SILAC) proteomics, CLPB and HAX1 control the balance of mitochondrial protein synthesis and persistence crucial for proper mitochondrial function. Impaired mitochondrial protein dynamics are associated with decreased abundance of the serine-threonine kinase PRKD2 and HSP27 phosphorylated on serines 78 and 82. Cellular defects in HAX1–/– cells can be functionally reconstituted by HSP27. Thus, mitochondrial proteostasis emerges as a critical molecular and metabolic mechanism governing the differentiation and function of neutrophil granulocytes.


  • Open Access

    Mepolizumab para el tratamiento de asma grave eosinofílica

    by Armando Partida-Gaytán, Luis Torre-Bouscoulet, Marco Polo Macías, Alejandro Raimondi, Emilio Pizzichini

    El asma grave es una enfermedad heterogénea y compleja que afecta aproximadamente al 5% de los pacientes con asma y se asocia a una importante carga de síntomas, exacerbaciones graves frecuentes e impactos negativos en la funcionalidad y calidad de vida. Diferentes estrategias de innovación han actualizado las opciones terapéuticas disponibles para estos pacientes, pero los anticuerpos monoclonales representan las alternativas con mayor relevancia clínica. Como especialistas en asma es importante mantenernos actualizados para poder identificar correctamente a aquellos pacientes que pueden beneficiarse del tratamiento con estos medicamentos. Este artículo ofrece una revisión actualizada y práctica enfocada en mepolizumab, un anticuerpo monoclonal humanizado anti-IL5 aprobado como tratamiento complementario en pacientes con asma grave eosinofílica. Los autores hemos realizado una síntesis de las evidencias de eficacia, seguridad y efectividad de mepolizumab con el objetivo de proveer una herramienta de consulta y apoyo en la toma de decisiones para el especialista que evalúa, diagnostica y trata pacientes con asma grave. Mepolizumab ha documentado en condiciones controladas de ensayos clínicos, y en estudios de vida real reducir consistente y significativamente las exacerbaciones de asma, mejorar el control de la enfermedad, mejorar la calidad de vida de los pacientes, y disminuir la dosis o retirar la exposición a corticoesteroides sistémicos.


  • Open Access

    Reference values for bone mineral density in healthy Mexican children and adolescents

    by Desiree Lopez-Gonzalez, Jonathan C. Wells, Mario Cortina-Borja, Mary Fewtrell, Armando Partida-Gaytán, Patricia Clark


  • Open Access

    Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines

    by Désirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jorge A. Luna-Pech, Mónica Rodríguez-González, María Virginia Blandón-Vijil, Blanca E. Del-Río-Navarro, María del Carmen Costa-Domínguez, Elsy Maureen Navarrete-Rodríguez, Carlos Macouzet-Sánchez, José Antonio Ortega-Martell, et al.


  • Open Access

    Obesogenic Lifestyle and Its Influence on Adiposity in Children and Adolescents, Evidence from Mexico

    by Desiree Lopez-Gonzalez, Armando Partida-Gaytán, Jonathan C. Wells, Pamela Reyes-Delpech, Fatima Avila-Rosano, Marcela Ortiz-Obregon, Frida Gomez-Mendoza, Laura Diaz-Escobar, Patricia Clark

    Overweight (OW) and obesity (OB) during childhood/adolescence are major public health problems in Mexico. Several obesogenic lifestyle (OL) risk factors have been identified, but the burden and consequences of them in Mexican children/adolescents remain unclear. The objective of this study was to estimate the prevalence of OL components and describe their relationships with adiposity, and OW/OB. A population-based cross-sectional study of Mexican children/adolescents with nutritional assessment, data collection on daily habits and adiposity as fat-mass index (FMI) by dual-energy X-ray absorptiometry was performed. Individual OL-components: “inactivity,” “excessive screen time,” “insufficient sleep,” “unhealthy-diet”, were defined according to non-adherence to previously published healthy recommendations. Results: 1449 subjects were assessed between March 2015 to April 2018. Sixteen percent of subjects had all four OL-components, 40% had three, 35% had two, 9% had one, and 0.5% had none. A cumulative OL score showed a significant dose–response effect with FMI. The combination of inactivity, excessive screen time, and insufficient sleep showed the highest risk association to OW/OB and higher values of FMI. Conclusions: The prevalence of OL-components was extremely high and associated with increased adiposity and OW/OB. Several interventions are needed to revert this major public health threat.


  • Latin American consensus on the supportive management of patients with severe combined immunodeficiency

    by Juan Carlos Bustamante Ogando, Armando Partida Gaytán, Juan Carlos Aldave Becerra, Aristóteles Álvarez Cardona, Liliana Bezrodnik, Arturo Borzutzky, Lizbeth Blancas Galicia, Diana Cabanillas, Antonio Condino-Neto, Agustín De Colsa Ranero, et al.


  • Open Access

    GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE

    by Désirée Larenas-Linnemann, Jorge A. Luna-Pech, Noel Rodríguez-Pérez, Mónica Rodríguez-González, Alfredo Arias-Cruz, María Virginia Blandón-Vijil, María del Carmen Costa-Domínguez, Blanca E. Del Río-Navarro, Alan Estrada-Cardona, Elsy Maureen Navarrete-Rodríguez, et al.

    Background: In Mexico, allergen immunotherapy (AIT) and immunotherapy with hymenoptera venom (VIT) is traditionally practiced combining aspects of the European and American school. In addition, both types of extracts (European and American) are commercially available in Mexico. Moreover, for an adequate AIT/VIT a timely diagnosis is crucial. Therefore, there is a need for a widely accepted, up-to-date national immunotherapy guideline that covers diagnostic issues, indications, dosage, mechanisms, adverse effects and future expectations of AIT (GUIMIT 2019).Method: With nationwide groups of allergists participating, including delegates from postgraduate training-programs in Allergy/Immunology-forming, the guideline document was developed according to the ADAPTE methodology: the immunotherapy guidelines from European Academy of Allergy and Clinical Immunology, German Society for Allergology and Clinical Immunology, The American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma, and Immunology were selected as mother guidelines, as they received the highest AGREE-II score among international guidelines available; their evidence conforms the scientific basis for this document.Results: GUIMIT emanates strong or weak (suggestions) recommendations about practical issues directly related to in vivo or in vitro diagnosis of IgE mediated allergic diseases and the preparation and application of AIT/VIT and its adverse effects. GUIMIT finishes with a perspective on AIT modalities for the future. All the statements were discussed and voted on until > 80 % consensus was reached.Conclusion: A wide and diverse group of AIT/VIT experts issued transculturized, evidence-based recommendations and reached consensus that might improve and standardize AIT practice in Mexico.


  • Open Access

    Datos bibliométricos y cienciométricos de Acta Pediátrica de México

    by Armando Partida Gaytán

    En los últimos 3 años, Acta Pediátrica de México (APM) ha reconfigurado su proceso de gestión editorial, pero la esencia de APM continúa siendo la misma que hace 37 años propusiera el Comité Editorial presidido por el Dr. Jorge Espino Vela: difundir los resultados de la labor asistencial, docente y de investigación de nuestras instituciones de salud, y en beneficio de la niñez mexicana.